Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study

Journal Title: Turkish Journal of Pathology - Year 2017, Vol 33, Issue 3

Abstract

Objective: Programmed cell death ligand-1 interacts with the immune receptors on the surface of CD8+ tumor infiltrating lymphocytes and PD-1, thereby blocking its anti-tumor activity. Therapeutics suppression of this interaction will show a promise in the treatment of non-small cell lung cancer by restoring the functional anti-tumor T-cell activity. We aimed to evaluate the association between the immunohistochemical expression of PD-L1, stromal CD8+ tumor infiltrating lymphocytes and p53 with the clinicopathological characteristics, response to chemotherapy, progression-free-survival, and overall survival. Material and Method: We examined the immunohistochemical expression of PD-L1, stromal CD8+ TILs, and p53 expression in 50 patients with advanced stage (III&IV) non-small cell lung cancer. Results: PD-L1 was expressed in 56% of the studied cases. PD-L1 expression was related to unfavorable response to the therapy without significant difference. PD-L1 expression was significantly associated with disease progression, poor progression-free-survival & overall survival. CD8+ TILs were high in 32% of the cases. Tumors with high CD8+ TILs showed a partial response to therapy and had a better progression-free-survival and overall survival. p53 expressed in 82% of the studied cases. There was a significant negative association between PD-L1 and CD8+ TILs (p=0.009), while a non-significant association was found between p53 and PD-L1 (p=0.183). Conclusion: PD-L1 overexpression is an unfavorable prognostic marker, while the high CD8 + TILs is a good prognostic marker in non-small cell lung cancer. PD-L1 immunohistochemical assessment may be used for the selection of patients legible for treatment with anti-PD-L1 therapy.

Authors and Affiliations

Hayam E. RASHED, Aziza E. ABDELRAHMAN, Mohamed ABDELGAWAD, Safa BALATA, Mohamed El SHABRAWY

Keywords

Related Articles

Bilateral Benign Kistik Over Teratomunda Hashimoto Hastalığı: Olgu Sunumu

Ovaryum teratomlarında her üç germ yaprağına ait çok çeşitli dokular görülmektedir. Matür kistik teratomların %10'unda tiroid dokusu bulunmaktadır. Burada tiroid hormonları normal olmasına rağmen antitiroid peroksidaz a...

We can Diagnose it if we Consider it. Diagnostic Pitfall for Placenta: Placental Mesenchymal Dysplasia

Placental mesenchymal dysplasia is an increasingly recognizable abnormality. Early cases have been confused with partial hydatidiform mole. Placental mesenchymal dysplasia is probably under-diagnosed because of being an...

Enteropati-tipi T-hücreli lenfoma olgularında EBER in situ hibridizasyon yöntemiyle Epstein-Barr virüs ilişkisinin araştırılması

“Enteropati-tipi T-hücreli lenfoma (ETTHL)”, intraepitelyal T-lenfositleri kökenli bir “matür ekstranodal T ve NK hücreli lenfoma” türüdür. Tüm non-Hodgkin lenfomalar içerisindeki oranı %1'in altındadır. Gelişiminde glia...

Mandibular Actinomyces Infection Mimicking a Malignancy: Case Report

Actinomycosis is a rare, chronic, suppurative and granulomatous disease caused by Actinomyces israelii, which is a filamentous, anaerobic, gram-positive, saprophytic organism in the oral cavity. Diagnosis of actinomycosi...

A Unique Immunofluorescence Protocol to Detect Protein Expression in Vascular Tissues: Tacking a Long Standing Pathological Hitch

Objective: Autofluorescence induced interference is one of the major drawbacks in immunofluorescence analysis of formalin-fixed paraffin-embedded tissues, as it decreases the signal-to-noise ratio of specific labeling. A...

Download PDF file
  • EP ID EP255197
  • DOI 10.5146/tjpath.2017.01398
  • Views 65
  • Downloads 0

How To Cite

Hayam E. RASHED, Aziza E. ABDELRAHMAN, Mohamed ABDELGAWAD, Safa BALATA, Mohamed El SHABRAWY (2017). Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study. Turkish Journal of Pathology, 33(3), 211-222. https://europub.co.uk/articles/-A-255197